TAMPA, Fla.--(BUSINESS WIRE)--Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") announces that its proprietary CE marked Nano-Capture ELISA assay and Nano-Sero IgG ELISA assay currently manufactured by the Company’s subsidiary in Kuopio, Finland, will be made in the United States for use in clinical trials, FDA approval and expanded distribution.
